Intermediate Monitoring, Sample Size Reassessment, and Multi-Treatment Optimal Response-Adaptive Designs for Phase III Clinical Trials with More Than One Constraint (Q3391873)

From MaRDI portal
scientific article
Language Label Description Also known as
English
Intermediate Monitoring, Sample Size Reassessment, and Multi-Treatment Optimal Response-Adaptive Designs for Phase III Clinical Trials with More Than One Constraint
scientific article

    Statements

    Intermediate Monitoring, Sample Size Reassessment, and Multi-Treatment Optimal Response-Adaptive Designs for Phase III Clinical Trials with More Than One Constraint (English)
    0 references
    0 references
    0 references
    13 August 2009
    0 references
    constraints
    0 references
    ethical allocation
    0 references
    group sequential designs
    0 references
    minimization
    0 references

    Identifiers

    0 references
    0 references
    0 references
    0 references
    0 references
    0 references